instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Drug ineffective'? | Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. Th... | Fatal | ReactionOutcome | CC BY | 34835220 | 20,339,934 | 2021-11-06 |
What was the outcome of reaction 'Fungal infection'? | Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. Th... | Recovered | ReactionOutcome | CC BY | 34835220 | 20,368,124 | 2021-11-06 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. Th... | Fatal | ReactionOutcome | CC BY | 34835220 | 20,339,934 | 2021-11-06 |
What was the outcome of reaction 'Neutropenia'? | Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. Th... | Recovered | ReactionOutcome | CC BY | 34835220 | 20,368,124 | 2021-11-06 |
What was the outcome of reaction 'Septic shock'? | Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. Th... | Fatal | ReactionOutcome | CC BY | 34835220 | 20,339,934 | 2021-11-06 |
What was the outcome of reaction 'Thrombocytopenia'? | Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies.
Saprochaete capitata is an arthroconidial yeast, found principally in the environment, even if it belongs also to the normal microbial flora that colonize human subjects. Th... | Recovered | ReactionOutcome | CC BY | 34835220 | 20,368,124 | 2021-11-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage intracranial'. | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | FONDAPARINUX | DrugsGivenReaction | CC BY | 34835275 | 20,203,148 | 2021-11-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | DANAPAROID SODIUM, FONDAPARINUX SODIUM | DrugsGivenReaction | CC BY | 34835275 | 20,193,015 | 2021-11-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | DANAPAROID SODIUM, FONDAPARINUX SODIUM | DrugsGivenReaction | CC BY | 34835275 | 20,193,015 | 2021-11-17 |
What was the administration route of drug 'FONDAPARINUX'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | Subcutaneous | DrugAdministrationRoute | CC BY | 34835275 | 20,203,148 | 2021-11-17 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34835275 | 20,193,507 | 2021-11-17 |
What was the administration route of drug 'PREDNISOLONE'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | Oral | DrugAdministrationRoute | CC BY | 34835275 | 20,193,507 | 2021-11-17 |
What was the dosage of drug 'PREDNISOLONE'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | 70 mg (milligrams). | DrugDosage | CC BY | 34835275 | 20,193,507 | 2021-11-17 |
What was the outcome of reaction 'Cerebral haemorrhage'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | Fatal | ReactionOutcome | CC BY | 34835275 | 20,193,507 | 2021-11-17 |
What was the outcome of reaction 'Haemorrhage intracranial'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | Fatal | ReactionOutcome | CC BY | 34835275 | 20,203,148 | 2021-11-17 |
What was the outcome of reaction 'Off label use'? | Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
OBJECTIVE
Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated ... | Fatal | ReactionOutcome | CC BY | 34835275 | 20,193,015 | 2021-11-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal discomfort'. | Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report.
BACKGROUND
Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function. However, l... | ASPIRIN, HYDROXYCHLOROQUINE SULFATE | DrugsGivenReaction | CC BY | 34836543 | 20,205,710 | 2021-11-26 |
What was the dosage of drug 'ASPIRIN'? | Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report.
BACKGROUND
Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function. However, l... | 1000 mg (milligrams). | DrugDosage | CC BY | 34836543 | 20,205,710 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | ASPIRIN, LATAMOXEF | DrugsGivenReaction | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eosinophil count increased'. | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | ASPIRIN, LATAMOXEF | DrugsGivenReaction | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash pruritic'. | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | ASPIRIN, LATAMOXEF | DrugsGivenReaction | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
What was the dosage of drug 'ASPIRIN'? | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | 3 MILLIGRAM/KILOGRAM, DAILY | DrugDosageText | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
What was the outcome of reaction 'Drug hypersensitivity'? | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | Recovered | ReactionOutcome | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
What was the outcome of reaction 'Eosinophil count increased'? | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | Recovered | ReactionOutcome | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
What was the outcome of reaction 'Rash pruritic'? | Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented.
We present a case of KD with eyelid ptosis and muscle weakness in a... | Recovered | ReactionOutcome | CC BY | 34837997 | 20,941,431 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Congenital hyperinsulinaemic hypoglycaemia'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deficiency of bile secretion'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperbilirubinaemia'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukoerythroblastosis'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | HUMAN RHO(D) IMMUNE GLOBULIN | DrugsGivenReaction | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What is the weight of the patient? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | 3.08 kg. | Weight | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the administration route of drug 'HUMAN RHO(D) IMMUNE GLOBULIN'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Transplacental | DrugAdministrationRoute | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the dosage of drug 'HUMAN RHO(D) IMMUNE GLOBULIN'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | MATERNAL DOSE: 300 ?G AT 30 WEEKS GESTATION | DrugDosageText | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Anaemia'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Congenital hyperinsulinaemic hypoglycaemia'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Deficiency of bile secretion'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Drug ineffective'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Hyperbilirubinaemia'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Hypoxia'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Leukoerythroblastosis'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
What was the outcome of reaction 'Thrombocytopenia'? | Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
BACKGROUND
In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anem... | Recovered | ReactionOutcome | CC BY | 34838142 | 20,200,522 | 2021-11-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series.
BACKGROUND
The Coronavirus disease 2019 (COVID-19) caused by the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a pandemic, affecting the therapeutic management for Multiple Sclerosi... | FINGOLIMOD | DrugsGivenReaction | CC BY | 34839814 | 20,697,861 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myxoid liposarcoma'. | Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series.
BACKGROUND
The Coronavirus disease 2019 (COVID-19) caused by the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a pandemic, affecting the therapeutic management for Multiple Sclerosi... | NATALIZUMAB | DrugsGivenReaction | CC BY | 34839814 | 20,201,068 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prescribed underdose'. | Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series.
BACKGROUND
The Coronavirus disease 2019 (COVID-19) caused by the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a pandemic, affecting the therapeutic management for Multiple Sclerosi... | NATALIZUMAB | DrugsGivenReaction | CC BY | 34839814 | 20,201,068 | 2021-11-29 |
What was the outcome of reaction 'Myxoid liposarcoma'? | Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series.
BACKGROUND
The Coronavirus disease 2019 (COVID-19) caused by the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a pandemic, affecting the therapeutic management for Multiple Sclerosi... | Recovered | ReactionOutcome | CC BY | 34839814 | 20,201,068 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Exuberant case of verrucous cutaneous leishmaniasis.
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down s... | AMPHOTERICIN B, ITRACONAZOLE, TERBINAFINE | DrugsGivenReaction | CC BY | 34839986 | 20,174,895 | 2021-11-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Exuberant case of verrucous cutaneous leishmaniasis.
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down s... | AMPHOTERICIN B, ITRACONAZOLE, TERBINAFINE | DrugsGivenReaction | CC BY | 34839986 | 20,174,895 | 2021-11-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Exuberant case of verrucous cutaneous leishmaniasis.
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down s... | AMPHOTERICIN B, ITRACONAZOLE, TERBINAFINE | DrugsGivenReaction | CC BY | 34839986 | 20,174,895 | 2021-11-25 |
What was the dosage of drug 'AMPHOTERICIN B'? | Exuberant case of verrucous cutaneous leishmaniasis.
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down s... | 3 g (grams). | DrugDosage | CC BY | 34839986 | 20,174,895 | 2021-11-25 |
What was the dosage of drug 'ITRACONAZOLE'? | Exuberant case of verrucous cutaneous leishmaniasis.
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down s... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 34839986 | 20,174,895 | 2021-11-25 |
What was the dosage of drug 'TERBINAFINE'? | Exuberant case of verrucous cutaneous leishmaniasis.
Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down s... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY | 34839986 | 20,174,895 | 2021-11-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'IgA nephropathy'. | IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis: A Case Study.
A 70-year-old man received pembrolizumab as a second-line treatment for squamous cell lung cancer of the lower right lobe. After three courses, proteinuria and hematuria were observe... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34840226 | 20,380,382 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tubulointerstitial nephritis'. | IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis: A Case Study.
A 70-year-old man received pembrolizumab as a second-line treatment for squamous cell lung cancer of the lower right lobe. After three courses, proteinuria and hematuria were observe... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34840226 | 20,380,382 | 2021-11-27 |
What was the administration route of drug 'PEMBROLIZUMAB'? | IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis: A Case Study.
A 70-year-old man received pembrolizumab as a second-line treatment for squamous cell lung cancer of the lower right lobe. After three courses, proteinuria and hematuria were observe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34840226 | 20,380,382 | 2021-11-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Atypical CML with TET2 mutation, associated with NRAS and KRAS: A case report and literature review.
Atypical chronic myeloid leukemia (BCR-ABL1 negative) is a rare myeloid neoplasm with poor prognosis and no current standard of treatment. It features both myelodysplastic and myeloproliferative characteristics with lit... | AZACITIDINE, HYDROXYUREA | DrugsGivenReaction | CC BY | 34840744 | 20,895,416 | 2021-11 |
What was the dosage of drug 'HYDROXYUREA'? | Atypical CML with TET2 mutation, associated with NRAS and KRAS: A case report and literature review.
Atypical chronic myeloid leukemia (BCR-ABL1 negative) is a rare myeloid neoplasm with poor prognosis and no current standard of treatment. It features both myelodysplastic and myeloproliferative characteristics with lit... | 20 MG, QD, (20MG 1 X 1) | DrugDosageText | CC BY | 34840744 | 20,895,416 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contusion'. | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | ACETAMINOPHEN, FAVIPIRAVIR, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34840780 | 20,219,451 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | ACETAMINOPHEN, FAVIPIRAVIR, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34840780 | 20,193,694 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | ACETAMINOPHEN, FAVIPIRAVIR, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34840780 | 20,193,694 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | ACETAMINOPHEN, FAVIPIRAVIR, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34840780 | 20,193,694 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombosis'. | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | ACETAMINOPHEN, FAVIPIRAVIR, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34840780 | 20,219,451 | 2021-12 |
What was the outcome of reaction 'Haemorrhage'? | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | Recovered | ReactionOutcome | CC BY | 34840780 | 20,193,694 | 2021-12 |
What was the outcome of reaction 'Thrombocytopenia'? | A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report.
Thrombocytopaenia, one of the most common haematological disorders worldwide, is characterised by platelet counts <150,000/mm3. Patients with coronavirus disease (COVID-19) were found to commonly exhibit haematological abnormalities, often wi... | Recovered | ReactionOutcome | CC BY | 34840780 | 20,193,694 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | ACETAMINOPHEN, AMIKACIN, AZITHROMYCIN, CEFOPERAZONE\SULBACTAM, CEFOTAXIME SODIUM, CILASTATIN SODIUM\IMIPENEM, ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE, LEVOFLOXACIN, MEROPENEM, METRONIDAZOLE, MICAFUNGIN SODIUM, MOXIFLOXACIN, TOCILIZUMAB, TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34840781 | 20,360,857 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | ACETAMINOPHEN, AMIKACIN, AZITHROMYCIN, CEFOPERAZONE\SULBACTAM, CEFOTAXIME SODIUM, CILASTATIN SODIUM\IMIPENEM, ENOXAPARIN, HUMAN PLASMA, HYDROXYCHLOROQUINE, LEVOFLOXACIN, MEROPENEM, METRONIDAZOLE, MICAFUNGIN, MOXIFLOXACIN, PANTOPRAZOLE, TOCILIZUMAB, TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34840781 | 20,351,819 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | ACETAMINOPHEN, AMIKACIN, AZITHROMYCIN, CEFOPERAZONE\SULBACTAM, CEFOTAXIME SODIUM, CILASTATIN SODIUM\IMIPENEM, ENOXAPARIN SODIUM, HYDROXYCHLOROQUINE, LEVOFLOXACIN, MEROPENEM, METRONIDAZOLE, MICAFUNGIN SODIUM, MOXIFLOXACIN, TOCILIZUMAB, TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34840781 | 20,360,857 | 2021-12 |
What was the dosage of drug 'HUMAN PLASMA'? | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | UNK (4 UNITS TRANSFUSED) | DrugDosageText | CC BY-NC-ND | 34840781 | 20,351,819 | 2021-12 |
What was the outcome of reaction 'Condition aggravated'? | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34840781 | 20,360,857 | 2021-12 |
What was the outcome of reaction 'Drug-induced liver injury'? | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34840781 | 20,360,857 | 2021-12 |
What was the outcome of reaction 'Off label use'? | Liver abscess with necrosis in post COVID-19: A case report.
Coronavirus disease 2019 (COVID-19) is an acute respiratory tract infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2). Recent evidences mentioned the possibility of COVID-19 as a systemic infectious and inflammatory disease. Signs ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34840781 | 20,360,857 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | CEFAZOLIN, CEFEPIME HYDROCHLORIDE, HEPARIN SODIUM, METRONIDAZOLE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34840847 | 20,291,143 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular pseudoaneurysm'. | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | CEFAZOLIN, CEFEPIME HYDROCHLORIDE, HEPARIN SODIUM, METRONIDAZOLE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34840847 | 20,291,143 | 2021 |
What was the administration route of drug 'CEFAZOLIN'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34840847 | 20,291,143 | 2021 |
What was the administration route of drug 'CEFEPIME HYDROCHLORIDE'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34840847 | 20,291,143 | 2021 |
What was the administration route of drug 'HEPARIN SODIUM'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34840847 | 20,291,143 | 2021 |
What was the administration route of drug 'METRONIDAZOLE'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34840847 | 20,291,143 | 2021 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34840847 | 20,291,143 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Recovering | ReactionOutcome | CC BY | 34840847 | 20,291,143 | 2021 |
What was the outcome of reaction 'Vascular pseudoaneurysm'? | A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm.
Pulmonary mycotic pseudoaneurysm is a rare complication of bacteremia with high associated mortality. We present a case of a large proximal pulmonary artery pseudoaneurysm as a result of methicillin-sensitive Staphylococcus aureus bacteremia, originat... | Recovering | ReactionOutcome | CC BY | 34840847 | 20,291,143 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | MEROPENEM, MICAFUNGIN SODIUM, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, VALGANCICLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34840851 | 20,186,662 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus viraemia'. | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | MEROPENEM, MICAFUNGIN SODIUM, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, VALGANCICLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34840851 | 20,186,662 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Human ehrlichiosis'. | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | MEROPENEM, MICAFUNGIN SODIUM, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, VALGANCICLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34840851 | 20,186,662 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | MEROPENEM, MICAFUNGIN SODIUM, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS, VALGANCICLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34840851 | 20,186,662 | 2021 |
What was the dosage of drug 'MICAFUNGIN SODIUM'? | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | DOSE ADJUSTED FOR RENAL FUNCTION | DrugDosageText | CC BY | 34840851 | 20,186,662 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | Recovered | ReactionOutcome | CC BY | 34840851 | 20,186,662 | 2021 |
What was the outcome of reaction 'Cytomegalovirus viraemia'? | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | Recovered | ReactionOutcome | CC BY | 34840851 | 20,186,662 | 2021 |
What was the outcome of reaction 'Human ehrlichiosis'? | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | Recovered | ReactionOutcome | CC BY | 34840851 | 20,186,662 | 2021 |
What was the outcome of reaction 'Septic shock'? | Challenges of Diagnosing Severe Ehrlichiosis in Orthotopic Liver Transplant Recipients.
In recent solid organ transplant recipients, acute febrile illness is usually a source of grave concern and a diagnostic dilemma, especially if no response is noted after initiation of broad antimicrobial therapy. Human Monocytic Eh... | Recovered | ReactionOutcome | CC BY | 34840851 | 20,186,662 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,193,693 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE, FILGRASTIM, MEROPENEM | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,257,230 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Empyema'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,215,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungal infection'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal perforation'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,185,713 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileal perforation'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.